Cardiovascular medicine Books

Book SynopsisThis title is part of UC Press's Voices Revived program, which commemorates University of California Press's mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1966.

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsThe ECG in healthy people The ECG in patients with palpitations and syncope: between attacks: initial assessment The ECG in patients with palpitations and syncope: between attacks: ambulatory ECG monitoring The ECG when the patient has a tachycardia The ECG when the patient has a bradycardia The ECG in patients with chest pain The ECG in patients with breathlessness The effect of other conditions on the ECG Conclusions: four steps to making the most of the ECG

Read more less

Book Synopsis

Read more less

Book SynopsisWhat drugs should be used to maintain someone in sinus rhythm who has paroxysmalatrial Fibrillation? How do I investigate the relatives of a patient with sudden cardiac death? Which cardiac patients should never get pregnant? This book answers these and other questions.Table of ContentsContributors. Introduction. 1. What are the cardiovascular risks of hypertension?. 2. Is 24 hour blood pressure monitoring necessary, and what do I do with the information?. 3. Who should be screened for a cause of secondary hypertension? How do I screen?. 4. What blood pressure should I treat, and what should I aim for when treating a 45 year old, a 60 year old, a 75 year old or an 85 year old?. 5. Is one treatment for hypertension proven to be better than another in terms of survival?. 6. It was once suggested that calcium channel blockers might be dangerous for treating hypertension. Is this still true?. 7. How can I outline a management plan for the patient with essential hypertension?. 8. How do I manage the patient with malignant hypertension?. 9. Which asymptomatic hypercholeterolaemic patients benefit from lipid-lowering therapy? What cholesterol level should I aim for?. 10.Which patients with coronary disease have been proven to benefit from pharmacological intervention? What lipid levels should I aim for?. 11.What drugs should I choose to treat dyslipidaemia, and how should I monitor treatment?. 12. What are the side effects of lipid-lowering therapy, and how should they be monitored?. 13. Is there a role for prescribing antioxidant vitamins to patients with coronary artery disease? If so, who should get them, and at what dose?. 14. What is the sensitivity, specificity and positive predictive value of an abnormal exercise test?. 15. What are the risks of exercise testing? What are the contraindications?. 16. What are the stratification data for risk from exercise tests in patients with angina? Which patterns of response warrant referral for angiography?. 17. Who should have a thallium scan? How does it compare with standard exercise tests in determining risk?. 18. What are hibernating and stunned myocardium? What echocardiographic techniques are useful for detecting them? How do these methods compare with others available?. 19. Which class of antianginal agent should I prescribe in stable angina? Does it matter?. 20. What is the role of troponin T in the diagnosis and risk stratification of acute coronary syndromes?. 21. What is the risks of myocardial infarction and death in someone with unstable angina during hospital admission, at six months and one year?. 22. What medical treatments of unstable angina are of proven benefit?. 23. Under what circumstances should the patient with unstable angina undergo PTCA or CABG?. 24. What new approaches are there to prevent restenosis following PTCA?. 25. Which thrombolytics are currently available for treating acute myocardial infrarction? Who should receive which one? What newer agents are there?. 26. Is angioplasty better than thrombolysis in myocardial infarction? Which patients should receive primary or "hot" angioplasty for these conditions?. 27. Whar are the contraindication to thrombolytic therapy for acute myocardial infarction? Is diabetic retinopathy a contraindication?. 28. Exercise testing after myocardial infarction: how soon, what protocol, how should results be acted upon?. 29. What are the risks of recurrent ischaemic events after myocardial infarction: prehospital, at 30 days and at 1 year?. 30. What is appropriate secondary prevention after acute myocardial infarction?. 31. What advice should I give patients about driving and flying after myocardial infarction?. 32. What is the mortality rate for cardiogenic shock complicating myocardial infarction? How should such patients be managed to improve outcome and what are the results?. 33. What is the risk of a patient dying or having a myocardial infarction around the time of surgery for coronary artery disease and for valve replacements?. 34. Which patients with post-infarct septal rupture should be treated surgically, and what are the success rates?. 35. What patterns of coronary disease are associated with improved short and long term survival after CABG compared with medical therapy?. 36. Coronary artery bypass grafting: what is the case for total arterial revascularization?. 37. How common are neuropsychological complications after cardiopulmonary bypass (CPB)? How predictable are severe are they? Can they be prevented?. 38. Are there benefits to switching from sulphonylureas to insulin after coronary artery bypass grafting?. 39. How does recent myocardial infarction affect the perioperative risks of coronary artery bypass grafting?. 40. How soon before cardiac surgery should aspirin be stopped?. 41. When should we operate to relieve mitral regurgitation?. 42. When to repair the miral valve?. 43. What is the Ross procedure? When is it indicated and what are the advantages?. 44. What is the risk of stroke each year after a) tissue or b) mechanical MVR or AVR? What is the annual risk of bacterial endocarditis on these prosthetic valves?. 45. When and how should a ventricular septal defect be closed in adults?. 46. How should I treat atrial septal defects in adults?. 47. How do I follow up a patient who has had correction of aortic coarctation? What should I look for and how should they be managed?. 48. How should I investigate a patient with hypertrophic cardiomyopathy (HCM)?. 49. What is the medical therapy for patients with hypertrophic cardiomyopathy, and what surgical options are of use?. 50. What is the role of permanent pacing in hypertrophic cardiomyopathy?. 51. How do I investigate protocol should a patient with hypertrophic cardiomyopathy? How should they be followed?. 52. What investigation protocol should a patient with dilated cardiomyopathy undergo?. 53. Which patients with impaired ventricles should receive an ACE inhibitor? We are the survival advantages? Do ATI-receptor antagonist confer the small advantages?. 54. What is the role of vasodilators in the chronic heart failure? Who should receive them?. 55. Should I give digoxin to patients with heart failure if they have sinus rhythm? If so, to whom? Are there dangers to stopping it once started?. 56. Which patient with heart failure should have a beta blocker? How do I start it and how should I monitor therapy?. 57. What is mean and model life expectancy in NYHA I-IV heart failure?. 58. What are LVADs and BIVADS, who should have them?. 59. Who is eligible heart or heart-lunging transplant? How do I assess suitability for transplantation?. 60. What are the survival figures for the heart and heart-lunging transplantation?. 61. What drugs do post-transplant patients require, and what are there side effects? How should I follow up such patients?. 62. Can a cardiac transplant patient get angina? How is this investigated?. 63. What drugs should be used to maintain someone in sinus rhythm who has paroxysmal atrial fibrillation? Is there a role for digoxin?. 64. Which patients with paroxysmal or chronic atrial fibrillation should I treat with aspirin, warfarin or neither?. 65. Which patients with SVT should be referred for an intracardiac electrophysiological study (EP study)? What are the success rates and risks of radiofrequency (RF) ablation?. 66. What drugs should I use for chemically cardioverting atrial fibrillation and when is DC cardioversion preferable?. 67. How long should someone with atrial fibrillation be anticoagulated before DC cadioversion, and how long should this be continued afterwards?. 68. What factors determine the chances of successful elective cardioversion from atrial fibrillation?. 69. What are the risks of elective DC cardioversion from atrial fibrillation?. 70. Are patients with atrial flutter at risk of embolisation when cardioverted? Do they need anticoagulation to cover the procedure?. 71. How do I assess the risk of CVA or TIA in a patient with chronic atrial fibrillation?. 72. How sensitive are transthoracic and transoesophageal echocardiography for the detection of thrombus in the left atrium?. 73. What are the roles of transthoracic and transoesophageal echocardiography in patients with a TIA or stroke?. 74. Which patient with a patent foramen ovale should be referred for closure?. 75. How should I investigate the patient with collapse? Who should have a tilt test, and what do I do if it is positive?. 76. What are the chances of a 24 hour tape detecting the causes for collapse in a patient? What other alternative monitoring devices are now available?. 77. Should the patient with trifascicular disease be routinely paced? If not, why not?. 78. Who should have VVI pacemakers and who should have dual chamber pacemakers? What are the risks of pacemaker insertion?. 79. Can a patient with a pacemaker touch an electric fence? …have an MRI scan? …go through airport metal detectors? …use a mobile phone?. 80. What do I do if a patient has a pacemaker and needs cardioversion?. 81. What do I do about non-sustained ventricular tachycardia on a 24 hour tape?. 82. How do I treat torsades de pointers at a cardiac arrest?. 83. How do I assess the patient with long QT? Should I screen relatives, and how? How do I treat them?. 84. How do I investigate the relatives of a patient with sudden cardiac death?. 85. What percentage of patients will suffer the complications of amiodarone therapy, and how reversible are the eye, lung, and liver changes? How do I assess thyroid function in someone on amiodarone therapy?. 86. Who should have a VT stimulation study? What are the risks and benefits?. 87. What are the indications for implantable cardioverter defibrillator (ICD) implantation and what are the survival benefits?. 88. How do I manage the patient with an ICD?. 89. How do I follow up the patient with the implantable cardioverter defibrillator?. 90. What do I do if an ICD keeps discharging?. 91. How do I manage the pregnant woman with dilated cardiomyopathy?. 92. How do I manage the pregnant woman with valve disease?. 93. Which cardiac patients should never get pregnant? Which cardiac patients should undergo elective Caesarean section?. 94. A patient is on life-long warfarin and wishes to become pregnant. How should she be managed?. 95. How should the anticoagulation of a patient with a mechanical heart valve be managed for elective surgery?. 96. What are the indications for surgical management of endocarditis?. 97. What is the morbidity and mortality of endocarditis with modern day management (and how many relapse)?. 98. What percentage of blood cultures will be positive in endocarditis?. 99. Which patients should receive antibiotic prophylaxis for endocarditis, and which procedures should be covered in this way?. 100. Which patients should undergo preoperative non-invasive investigations or coronary angiography?. 101. Which factors predict cardiac risk from general surgery and what is the magnitude of the risks associated with each factor?. Index.. . .

Read more less

Book SynopsisIncluding 200 traces to test your knowledge, this book is a class learning tool for emergency physicians. This book is accompanied by learning points, and with the cases presented randomly, it provides a source of information on the interpretation of ECGs - a core skill for emergency department staff.Trade Review"Mattu and Brady have put together 200 ECGs that illustrate virtually all electrocardiographic diagnoses. This is achieved in a self-assessment format that is instructive and interesting...I recommend these as continuing education for Emergency Medicine Specialists: no matter how well honed your skills, there is something here that will make you stop, think and learn...After you have read this book, I suspect the next person to ask you "Just check this ECG" will be overwhelmed with your knowledge!" EMJ OnlineTable of ContentsForeword. Preface. Dedications. Part 1. Case histories. ECG interpretations and comments. Part 2. Case histories. ECG interpretations and comments. Appendix A: Differential diagnoses. Appendix B: Commonly used abbreviations. Index

Read more less

Book SynopsisThis textbook covers all the main subspecialties in cardiology, including a large proportion of case studies that illustrate the principles of clinical practice. Self testing questions accompany each case. Authored by leading cardiologists, this is an up to date, well illustrated, core cardiological text for those preparing for the specialist examinations. Contents: History and physical examination, ECG, CSR; non-invasive imaging and stress testing; catheterisation diagnostic and therapeutic uses; hypertension primary and secondary; atherosclerosis epidemiology, risk factors, lipoprotein abnormalities, diagnosis and treatment; acute coronary syndromes; chronic ischaemic heart disease; arrhythmias; cardiac arrest and resuscitation; heart failure and cardiac transplantation; congenital heart disease; valvular heart disease and infective endocarditis; pericardial disease, diseases of the aorta, heart tumours; pulmonary embolism and pulmonary hypertension; non-cardiac surgeTable of ContentsCardiac history and examination. Cardiac non-invasive imaging and stress testing. Cardiac catheterization. Hypertension. Lipid disorders. Acute coronary syndromes. Chronic ischemic heart disease. Arrhythmias. Sudden cardiac death and resuscitation. Heart failure and cardiac transplantation. Congenital heart disease. Valvular disease and infective endocarditis. Pericardial disease, disease of the aorta, and heart tumours. Pulmonary embolism and pulmonary hypertension. Non-cardiac surgery in patients with heart disease. Heart disease in pregnancy. Cardiovascular pharmacology. Arterial vascular disease

Read more less

Book Synopsis

Read more less

Book SynopsisEvery day, 2,600 Americans die of cardiovascular disease—and despite remarkable interventional and surgical procedures, over 650,000 new heart attacks occur annually.In The Heart Speaks, Dr. Mimi Guarneri reveals groundbreaking new research that the heart is a multilayered, complex organ, possessing intelligence, memory, and decision-making abilities independent from the mind—and that healing the heart can have more to do with healing the mind and soul than we ever knew. From childhood in a family riddled with heart disease to a medical career facing the pounding heartbeats of cardiac emergencies, Dr. Guarneri draws us into the intimate moments of life and death, and leads us on a riveting exploration of the heart''s many mysteries. Through her compelling memoir we see that it is only by knowing the whole heart—its mental, emotional, spiritual, and universal aspects—that we can truly heal.

Read more less

Book SynopsisGive your heart the best chance of carrying on beating for many years to come.Table of ContentsContents: Introduction 71 How your heart works 102 Common symptoms 173 Checking out your heart 234 Chest pain 335 Trouble with valves 496 Electrical problems (arrhythmias) 587 When the muscle malfunctions 698 High blood pressure (hypertension) 759 Looking after your heart 8710 Living with heart disease 99Appendix: Further sources of adviceand information 106

Read more less

Book SynopsisAn estimated 30,000 children are born in the USA with congenital heart disease each year, two thirds of which will require corrective surgery. Medical advances have formed a trend of operating on newborns rather than waiting until the child is older. Ten years ago, the mortality for these operationswas 60% to 70%. That percentage has dropped to 2%. This specialized book explores the basic mechanisms of neurologic injury associated with congenital heart surgery while covering the emerging technologies for assessment of neurologic integrity and injury. The text also highlights the current and future techniques for reducing and preventing these injuries, and reviews the pertinent medicolegal issues.Trade ReviewI found this book very interesting and informative. I recommend this book to END technologist who monitor pediatric cardiac patients and who would like to better understand the mechanisms of brain injury to the patient population during surgery... The book raises many questions and provides a great resource for determining what additional studies are required to ensure the most positive post-surgical outcomes. American Journal of Electroneurodiagnostic TechnolTable of ContentsPART I DEVELOPMENT OF THE CENTRAL NERVOUS SYSTEM: Brain Development and its Relationship to PAtterns of Injury Maturation of Brain ATP Metabolism EEG Maturation with Special Reference to Epiletogenic Effects of Hypoxia Programmed Cell Death The Biology of Cell Death in the Nematode Caenorhabditid elegans and Implications for the Understanding and Treatment of Human Brain Injury after Cardiac Surgery. PART II ASSESSMENT OF CNS FUNCTION: The Neurological Examination Cognitive and Psychomotor Developmental Assessment EEG Methods with PArticular Reference to Neonatal Seizures Transcranial Doppler Technology: The Noninvasive Monitoring of Cerebral Perfusion During Cardiopulmonary Bypass PET and SPECT in the Assessment of Cerebral Function Brain Monitoring Using Optical Imaging and Optical Spectroscopy Assessment of CNS Function: Cerebral Blood Flow and Metabolism Cerebral Evaluation with Nuclear Magnetic Resonance Spectroscopy. PART III MECHANISMS OF NEUROLOGICAL INJURY: Mechanisms of Perinatal Ischemic Brain Damage Endothelial and White Cell Activation in Bypass and Reperfusion Injury: Brain Injury Excitotoxicity and Nitric Oxide. PART IV CLINICAL AND LABORATORY STUDIES OF CARDIOPULMONARY BYPASS, HYPOTHERMIA AND CIRCULATORY ARREST: A Newborn Canine Model of Hypothermic Circulatory Arrest Effects on CPB, Hypothermia and Circulatory Arrests on Cerebral Blood Flow and Metabolism Assessment by NMRS of the Effects of Cardiopulmonary Bypass, Hypothermia and Circulatory Arrest pH MANAGEMENT During Hypothermic Cardiopulmonary Bypass with Circulatory Arrest. PART V A PROSPECTIVE CLINICAL STUDY OF CIRCULATORY ARREST AT CHILDREN'S HOSPITAL, BOSTON: Methods and Procedures EEG Findings Neurologic and MRI Findings

Read more less

Book SynopsisOver twelve million people in the UK have high blood pressure. Although prescription drugs may effectively treat this problem, they have potentially dangerous side effects. Fortunately, natural alternatives are available. In this updated third edition of LOWER BLOOD PRESSURE WITHOUT DRUGS, best-selling author Roger Mason provides a proven nutritional approach to lowering blood pressure safely and naturally.The book begins by explaining what hypertension is, what causes it, and how it is diagnosed. From there, it goes on to describe how a simple diet, rich in whole grains and low in fat, can improve both blood pressure and general health. This is followed by chapters that address such key topics as the best nutritional supplements to take; which exercises are most effective; how to maintain hormonal balance; and, just as important, how to overcome poor dietary and lifestyle habits. LOWER BLOOD PRESSURE WITHOUT DRUGS can be your first step towards safely and effectively improving your he

Read more less

Book SynopsisBased on Dr. Driscoll's thirty years of successful bedside teaching at the Mayo Clinic, Fundamentals of Pediatric Cardiology is the ideal textbook for residents in pediatrics, family medicine, internal medicine, and pediatric and adult cardiology. This concise, well-organized, and easy-to-understand text can be read cover-to-cover during a pediatric cardiology rotation and focuses sharply on what primary care physicians need to know for initial evaluation and management of patients.Dr. Driscoll explains the many types of congenital heart defects, focusing on the most frequent cardiac problems in infants, children, and adolescents. Emphasis is on use of new diagnostic tools in conjunction with the physical examination. Table of ContentsCardiovascular PhysiologyClinical Evaluation History Physical ExaminationBasic Diagnostic Studies Electrocardiography Radiography Echocardiography Cardiac CatheterizationExercise PhysiologyInnocent MurmursChest PainSyncope and Sudden DeathPrinciples of Inheritance and Genetics of Congenital Heart DiseaseLeft-to-Right Shunts Introduction Atrial Septal Defects Ventricular Septal Defects Patent Ductus Arteriosus Atrioventricular Septal Defects Truncus Arteriosus Aorticopulmonary Window Arteriovenous FistulaeRight-to-Left Shunts Introduction Transposition of the Great Arteries Tetralogy of Fallot and Pulmonary Atresia with VSD Truncus Arteriosus Tricuspid Atresia Univentricular Heart The Hypoplastic Left Heart Syndrome Ebstein Anomaly Pulmonary Atresia and Intact Ventricular Septum Totally Anomalous Pulmonary Venous Return ShockObstructive and Regurgitant Lesions Aortic Stenosis and Insufficiency Pulmonary Stenosis and Insufficiency Coarctation of the Aorta Mitral Stenosis and InsufficiencyAcquired Heart Disease Rheumatic Fever and Kawasaki Disease Kawasaki Disease Infective EndocarditisCardiomyopathyCoronary Artery Anomalies

Read more less

Book SynopsisReduce your risk of heart disease--the leading cause of death among Americans--with diet, exercise, and other health strategies from WebMD’s Dr. John Whyte.

Read more less

Book SynopsisThe first edition of this manual appeared in 1992 and was entitled ECAT Assay Procedures. It was the result of a unique cooperation between experts brought together by the European Concerted Action on Thrombosis and Disabilities (ECAT). The Concerted Action was at that time under the auspices of the Commission of the European Union. The second edition, like the first edition, deals with diagnostic tests within the field of thrombosis. However, the second edition has a broader scope because it is no longer limited by the frontiers of ECAT. Experts allover the world, in and outside ECAT, have contributed to this edition. The editors are very grateful for their contributions. The need for a new edition is obvious. Since 1992 new assays have been introduced for research, diagnosis, and therapy of thrombosis; for other assays improvements have been suggested, while a few others becameTrade Review`The objective towards standardization is largely met, since world experts on each assay collaborated to evaluate and compare the available methodologies and point to the advantages and disadvantages of each one. This book is written for clinical thrombosis and hemostasis laboratorians. Another attractive feature is the degree of expertise recruited to produce these critical summaries of existing methodologies. This book is a long overdue update of the first edition in view of the multitude of newly developed methodologies and the number of manufacturers involved.' Demetra D. Callas, Loyola University Medical Center in Doody Publishing Inc. Table of ContentsList of Contributors. Nomenclature of Haemostasis Factors. 1. Introduction to Laboratory Assays in Haemostasis and Thrombosis; J.Gram, J. Jespersen. 2. Good Medical Laboratory Services - Guidelines; J.-C. Libeer. 3. Blood Collection and Sample Preparation: Pre-analytical Variation; I.D. Walker. 4. Quality Assessment of Haemostatic Assays and External Quality Assessment Schemes; T.A.L. Woods, et al. 5. Activated Partial Thromboplastin Time (APTT); L. Poller. 6. Prothrombin Time (PT); L. Poller. 7. Endogenous Thrombin Potential; H.C. Hemker, S. Béguin. 8. Fibrinogen; M.P.M. de Maat, et al.9. Activated Factor VII; J.H. Morrissey. 10. Factor VII Activity and Antigen; G. Mariani, et al. 11. Factor VIII Clotting Activity; P.M. Mannucci, A. Tripodi. 12. Von Willebrand Factor; P.M. Mannucci, R. Coppola. 13. Antithrombin Activity and Antigen; J. Conard. 14. Protein C Activity and Antigen; R.M. Bertina. 15. Protein S Antigen; R.M. Bertina. 16. Protein S Activity Assays; E.M. Faioni. 17. Activated Protein C (APC) Resistance; A. Tripodi. 18. Tissue Factor Pathway Inhibitor (TFPI); P.M. Sandset. 19. Lupus Anticoagulant; D.A. Triplett. 20. Heparin Cofactor II; S.J. Bauman, F.C. Church. 21. Fibrinopeptide A (FPA); A. Haeberli. 22. Thrombin-Antithrombin (TAT) Complexes; J. Harenberg. 23. Prothrombin Fragment F 1+ 2; A. Haeberli. 24. Plasma Tissue-Type Plasminogen Activator (t-PA) Activity; C. Kluft, et al. 25. Tissue Type Plasminogen Activator Antigen (t-PA Ag); M.Ch. Alessi, I. Juhan-Vague. 26. Plasminogen Activator Inhibitor-1(PAI-1) Antigen; P.J. Declerk. 27. Plasminogen Activity; P.J. Gaffney. 28. Plasma Plasmin Inhibitor* Activity (*Previously &agr;2-Antiplasmin); C. Kluft, P. Meyer. 29. Plasmin-&agr;2-Antiplasmin Complexes (Plasmin-Plasmin Inhibitor Complexes); E. Hattey, et al. 30. Soluble Fibrin and Degradation Products of Fibrinogen (FgDP), Fibrin (FbDP;D-dimer) and Total of FgDP and FbDP (TDP); W. Nieuwenhuizen, R. Bos. 31. Venous Occlusion Test in Fibrinolysis Assays; J. Jespersen. 32. List of Manufacturers. Index.

Read more less

Book SynopsisIllustrations, questionnaires, patient vignettes, answers to commonly asked questions, and a list of additional resources round out this comprehensive patient guide.Trade ReviewCheskin and Lacy provide useful and informative guidance to a problem widespread in the U.S. today... They explode several myths, among them that acid isn't the only chemical that causes gastroesophageal reflux disease (GERD); that sufferers don't produce more stomach acid than their nonsuffering friends; and that spicy foods won't provoke GERD. As for interesting truths, they tell us that many have GERD without symptoms and that there is an interesting relationship between GERD and asthma. Booklist [ Healing Heartburn] distinguishes itself by appealing to a lay audience without insulting the clinician... a welcome addition to those interested in the prevalent disorder of GERD. -- Joseph Boullata Nutrition in Clinical Practice Anyone who has popped an antacid after a fiery bowl of chili... Should welcome [this book]. -- John Langone New York Times A well-written book and an invaluable resource for patients with GERD (Gastroesophageal reflux disease). -- Sanjib P. Mohanty, M.D. and Douglas Morgan, M.D., M.P.H. Gastroenterology 2003Table of ContentsContents: Part I. Introduction Contents: 1. What is Gastroesophageal Reflux Disease? 2. What Goes Wrong in GERD, and Where It Goes WrongPart II. Symptoms & Diseases 3. What Are the Symptoms of GERD? 4 Diagnosing GERDPart III. Treatment: The Four-Step Approach 5. Step 1: Lifestyle Modifications 6. Step 2: Over-the-Counter Medicines 7. Step 3 & 4: Prescription Medicines and SurgeryPart IV. Complications & Special Situations 8. Complications of GERD 9. GERD in Shildren, Pregnant Women, the Older Patient, and the Bed-BoundPart V. The Future 10. A Look into the Future: Diagnosing and Treating GERD and Complications of GERD Abbreviations Glossary Where to Go for Further Information and Support Index

Read more less

Book SynopsisIllustrations, questionnaires, patient vignettes, answers to commonly asked questions, and a list of additional resources round out this comprehensive patient guide.Trade ReviewCheskin and Lacy provide useful and informative guidance to a problem widespread in the U.S. today... They explode several myths, among them that acid isn't the only chemical that causes gastroesophageal reflux disease (GERD); that sufferers don't produce more stomach acid than their nonsuffering friends; and that spicy foods won't provoke GERD. As for interesting truths, they tell us that many have GERD without symptoms and that there is an interesting relationship between GERD and asthma. Booklist [ Healing Heartburn] distinguishes itself by appealing to a lay audience without insulting the clinician... a welcome addition to those interested in the prevalent disorder of GERD. -- Joseph Boullata Nutrition in Clinical Practice Anyone who has popped an antacid after a fiery bowl of chili... Should welcome [this book]. -- John Langone New York Times A well-written book and an invaluable resource for patients with GERD (Gastroesophageal reflux disease). -- Sanjib P. Mohanty, M.D. and Douglas Morgan, M.D., M.P.H. Gastroenterology 2003Table of ContentsContents: Part I. Introduction Contents: 1. What is Gastroesophageal Reflux Disease? 2. What Goes Wrong in GERD, and Where It Goes WrongPart II. Symptoms & Diseases 3. What Are the Symptoms of GERD? 4 Diagnosing GERDPart III. Treatment: The Four-Step Approach 5. Step 1: Lifestyle Modifications 6. Step 2: Over-the-Counter Medicines 7. Step 3 & 4: Prescription Medicines and SurgeryPart IV. Complications & Special Situations 8. Complications of GERD 9. GERD in Shildren, Pregnant Women, the Older Patient, and the Bed-BoundPart V. The Future 10. A Look into the Future: Diagnosing and Treating GERD and Complications of GERD Abbreviations Glossary Where to Go for Further Information and Support Index

Read more less

Book SynopsisThis valuable resource will help patients and their families make some of the most important health care decisions they will ever face.Trade ReviewThis book is excellent at explaining the causes of heart disease and the science behind diagnosis and treatment. Library Journal 2008 Covers every treatment option available, and includes illustrations and graphs to help the information sink in. Pittsburgh Magazine 2009 [Living with Coronary Heart Disease] offers a solid background to educate those who experience heart disease... you can keep yourself fully informed with this book. -- David Keeber Sedona Red Rock News 2009 I recommend this book as a valuable insight into the coronary heart disease process. -- Jane Bridges Nursing Standard 2009Table of ContentsPrefaceIntroduction1. What Is Coronary Heart Disease?2. How Did This Happen?3. What Is a Heart Attack?4. Did I Do Something to Cause This?5. How Do I Know If I Have Coronary Heart Disease?6. What Are All These Medications For?7. When Does Balloon Surgery Help?8. When Is Surgery the Best Treatment?9. Living with Coronary Heart DiseaseIndex

Read more less

Book SynopsisWalks you step by step through every aspect of ECG interpretation to develop the pattern recognition skills you need to read ECGs with confidence. 550 full-size, real-life ECG strips, a wealth of exercises, and practice tests help to ensure that you can recognise the subtle findings that distinguish one arrhythmia from another.Table of Contents I. Heart Structure and Electrical Activity 1. Anatomy and Physiology of the Heart 2. The Electrocardiogram II. Rhythms and Their Analysis 3. Sinoatrial Node Arrhythmias 4. Atrial Arrhythmias 5. Junctional Arrhythmias 6. Ventricular Arrhythmias 7. Atrioventricular and Bundle Branch Blocks 8. Artificial Cardiac Pacemakers 9. Electrocardiogram Artifact 10. The 12-Lead ECG and Acute Myocardial Infarction III. ECG Practice Tests 11. ECG Practice Test One 12. ECG Practice Test Two 13. ECG Practice Test Three 14. ECG Practice Test Four Answers to Practice Test Four Selected References Index Identifying Features of Arrhythmias Six Easy Steps in Analyzing ECG Strips

Read more less

Book SynopsisThis book addresses consequences on the cardiovascular system that arise from iatrogenesis— the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors.Table of ContentsTABLE OF CONTENTS Part I: MEDICAL HARM 1. The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis 2. Iatrogenicity: Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis 3. Epidemiology and Public Health Aspects and Implications: Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez 4. Risk Management: The Medical Center Administration Perspective S. Jones and M. Gonzalez 5. Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez 6. A Naturopathic Perspective on Iatrogenesis C. Fleetwood Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis 8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen 9. Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup 10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis 11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris 12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone 13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris 14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips 15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis 16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas 17. Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis 18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar 19. Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. Dösch, D. Loßnitzer, T. Papavassiliu 21. Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta 22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin 23. Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. Tülümen, and V. Liebe 24. Iatrogenic Aspects in Cardiac Device Therapy S. Röger and J. Kuschyk 25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. Santiago Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26. Professional Athletes G. Mancia 27. Sports Cardiology G. Campanile 28. Dangers of Lifestyle Modification Advice G. Campanile Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins: Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir 30. Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir Acknowledgments Index

Read more less

Book SynopsisThis book addresses consequences on the cardiovascular system that arise from iatrogenesis— the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors.Table of ContentsTABLE OF CONTENTS Part I: MEDICAL HARM 1. The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis 2. Iatrogenicity: Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis 3. Epidemiology and Public Health Aspects and Implications: Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez 4. Risk Management: The Medical Center Administration Perspective S. Jones and M. Gonzalez 5. Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez 6. A Naturopathic Perspective on Iatrogenesis C. Fleetwood Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis 8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen 9. Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup 10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis 11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris 12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone 13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris 14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips 15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis 16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas 17. Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis 18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar 19. Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. Dösch, D. Loßnitzer, T. Papavassiliu 21. Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta 22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin 23. Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. Tülümen, and V. Liebe 24. Iatrogenic Aspects in Cardiac Device Therapy S. Röger and J. Kuschyk 25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. Santiago Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26. Professional Athletes G. Mancia 27. Sports Cardiology G. Campanile 28. Dangers of Lifestyle Modification Advice G. Campanile Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins: Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir 30. Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir Acknowledgments Index

Read more less

Book SynopsisStroke is the fourth leading cause of death in the United States. Despite the frequency and morbidity of stroke, there is a relative paucity of “stroke experts” for these patients. Ischemic Stroke closes the gap in stroke care by providing a cogent and intuitive guide for all physicians caring for stroke patients.Table of ContentsTABLE OF CONTENTS 1 Emergent Evaluation of the Suspected Stroke Patient 2 Clinical Signs and Symptoms of Stroke 3 Mechanisms of Ischemic Stroke 4 Neuroimaging of Acute Stroke 5 Cardiac-Based Evaluation of Ischemic Stroke 6 Thrombolytic Therapy for Acute Ischemic Stroke 7 Endovascular Management of Acute Ischemic Stroke 8 Critical Care Management of Ischemic Stroke 9 Stroke Rehabilitation 10 Cardiac Arrhythmias and Stroke 11 Secondary Prevention of Cardiogenic Stroke 12 Treatment of Symptomatic Carotid Stenosis 13 Intracranial Large Vessel Disease 14 Small Vessel Disease 15 Cryptogenic Stroke Index

Read more less

Book SynopsisProvides an insider's perspective on the field of cardiovascular medicine told through vignettes and insights drawn from Gregory Chapman's three decades of experience. In twenty-six bite-sized chapters, Chapman provides an overview of cardiovascular diseases and treatments, illuminating the art and science of medical practice.Trade ReviewA Strong and Steady Pulse presents a collection of true-to-life anecdotes that will delight the health professional, medical aficionado, or anyone who loves a good story. Dr. Chapman manages to inform the fascinating clinical and scientific experiences of a life dedicated to cardiology with a compelling thread of humanity and good humor that renders this book at once instructional and universal. Both entertaining and enlightening, reading this book will make you smarter and more human—a welcome, feel good read with substance!"" - John W. Stewart III, PhD, President, the University of Montevallo""Educating, entertaining, and surprising. You will never look at your heart the same again."" - T.K. Thorne, author of Last Chance for Justice""Dr. Chapman, through his patients’ histories, shares his experiences and insights across three decades of caring for patients with cardiovascular disease. I highly recommend his well-written, easy-to-read narrative not only to health care providers and their students, but also to patients. All will benefit from a better understanding of their care."" - F. Andrew Gaffney, MD, Professor of Medicine, Vanderbilt University""In A Strong and Steady Pulse, Greg Chapman balances medical information with good storytelling. There is a chapter on COVID-19 and its impact on cardiac patients. There are also deeply touching narratives about a mother who has just delivered her first child and finds herself experiencing heart palpitations, fearing she will not live to see her son into adulthood, and about a son who is outraged over the thought of his mother being prescribed a statin. Simply put, the book is real life. It offers a bird’s-eye view of cardiology practice and a diverse community of patients who are battling heart disease and other ailments. The author’s balance between medicine and humanity is impeccable; readers will find this one compelling."" - Rachel Waide, JD, Tupelo, Mississippi attorney""Dr. Chapman uses patient stories as a powerful teaching tool for cardiology concepts. More importantly, his stories remind us of the privilege and responsibility of caring for patients. It is a must read for all who care for patients, especially in the field of general medicine and cardiology."" - Lisa Willett, MD, Professor of Medicine, Vice Chair for Medical Education, and Internal Medicine Residency Program Director, the University of Alabama at Birmingham""Medicine is both an art and a science. These two realms merge regularly in our conversations and interactions with patients and their families, often times when we least expect it. In this wonderful book of medical vignettes, Dr, Chapman, an interventional cardiologist, recounts poignant stories about his patients and his life that link the art and science of medicine, and in the end, generate wisdom that will be appreciated by patients and physicians alike."" - Sumanth D. Prabhu, MD, Professor of Medicine, Director, Division of Cardiovascular Disease, University of Alabama at Birmingham""Dr. Chapman provides readers with an inside view of medical practice in a way that shares the ‘science of medicine’ while personalizing the stories of the people living through serious medical conditions. Every scenario has an interesting twist with a medical response that is specific to the patient or is compared with others who have had similar experiences. These stories epitomize the art and science of medicine and why we respect individuals, like Dr. Chapman, who truly care about their patients. I recommend this book for aspiring health professionals as well as those who need to reach back to rediscover why they chose to serve in the health care field."" - Martha Lavender, PhD, Fellow, the American Academy of Nursing, and Member, the State of Alabama Nursing Hall of Fame""A Strong and Steady Pulse is as instructive as it is fun to read. It wonderfully reflects Dr. Chapman’s wit and charm."" - Marc G. Cribbs, MD, Director, Alabama Adult Congenital Heart Program, and Director of the UAB Comprehensive Pregnancy and Heart Program

Read more less

Book SynopsisVulnerable plaque development is the result of a complex series of molecular and cellular events involving inflammation, apoptosis, rupture, and thrombosis. A detailed understanding of the mechanisms underlying the development of high-risk plaques, along with the ability to visualize and diagnose these vulnerable lesions, will lead to the effective management of acute coronary syndromes.High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy brings together timely, in-depth reviews by renowned international cardiologists and scientists. Chapters cover the definition, structure, and cellular and molecular mechanisms of high risk plaque development, as well as animal models of vulnerable plaque, plaque imaging, and current and future therapies. Medical experts discuss intravascular ultrasound, optimal coherence tomography, magnetic resonance imaging, and coronary thermography. The final chapter reviews both current and future local and systematic strategies foTable of ContentsForeword. Cellular and Molecular Mechanisms of Plaque Rupture. Apoptosis and Plaque Vulnerability. Animal Models of Vulnerable Plaque. Diagnosis of Vulnerable Plaques in the Cardiac Catheterization Laboratory. Imaging of the High Risk Atherosclerotic Plaque by Intravascular Ultrasound: Focal Assessment of Morphology and Vulnerability or Systemic Assessment of Disease Burden and Activity? Optical Coherence Tomography for Detection of Vulnerable Plaque. Magnetic Resonance Imaging of "High Risk" Plaque. Nuclear Imaging of the Vulnerable Plaque: Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). Identification of the Vulnerable Plaque: The Role of Thermography. Treatment of Vulnerable Plaque: Current and Future Strategies.

Read more less

Book Synopsishis book provides a comprehensive summary of data from basic research on characterization, regulation, and function of heme oxygenase in mammalian systems. The book also includes a major section that covers the currently used clinical methods to suppress neonatal jaundice with emphasis on the newly developed use of synthetic metalloporophyrins. This book will be welcomed by researchers and students in pharmacology, biochemistry, pharmacy, neonatology, hematology, internal medicine, and endocrinology.Table of ContentsAN OVERVIEW OF PORPHYRINS AND HEMES AND THEIR BIOSYNTHETIC PATHWAY. Introduction. Porphyrins and Metalloporphyrins-General Properties. d-Aminolevulinate Synthetase. d-Aminolevulinate Dehydratase. Porphobilinogen Deaminase and Uroporphyrinogen III Synthetase. Uroporphyrinogen III Decarboxylase. Coproporphyrinogen Oxidase. Protoporphyrin Oxidase. Ferrochelatase. Disorders of Porphyrin Metabolism (Porphyrias). References. BILIVERDIN REDUCTASE. Introduction. References. HEME OXYGENASE AND HEME DEGRADING SYSTEMS. Introduction. Nonenzymatic Degradation of Heme by Heme Oxygenase. Enzymatic Degradation of Heme by Heme Oxygenase. References. CHARACTERIZATION AND REGULATION OF HEME OXYGENASE ISOZYMES AT THE MOLECULAR LEVEL. Background. Molecular and Biochemical Properties of Heme Oxygenase Isozymes. Molecular Cloning and Characterization of HO-1 and HO-2. References. REGULATION OF HEME OXYGENASE ACTIVITY. RESULTANT MODULATING EFFECT ON HEMOPROTEIN-DEPENDENT FUNCTIONS. Introduction. Mechanisms of Heme Oxygenase Regulation. Consequences of Induction of Heme Oxygenase on Drug Steroid and Prostaglandin Metabolic Systems. References. NEONATAL JAUNDICE. Introduction: Jaundice in the Newborn. Factors Influencing Serum Bilirubin Levels in the Newborn. Toxicity of Bilirubin to the Newborn. Developmental Changes in Cellular Ability to Produce Bilirubin in the Newborn. Possible Physiological Importance of Bilirubin. Treatment of Hyperbilirubinemia. References.

Read more less

Book SynopsisCell Interactions in Atherosclerosis covers the scientific foundations of the most important disease inflicting the developed world today. It presents a collection of topical aspects on the general theme of cell interactions in atherosclerosis, providing authoritative, up-to-the-minute accounts of how new developments in cell biology have advanced our understanding of these cellular interactions. The book is amply illustrated with electron micrographs and light micrographs incorporating modern cytochemical procedures. Cell Interactions in Atherosclerosis will interest all medical and scientific professionals dealing with atherosclerosis and heart disease.Table of ContentsConstituents of the Arterial Wall and Atherosclerotic Plaque: An Introduction to Atherosclerosis (Nicholas J. Severs and Horst Robenek). Three-Dimensional Organization of the Intima of Rabbit Aorta in Early Atherosclerotic Lesion Development as Viewed by Quick-Freeze, Deep-Etch Electron Microscopy (Joy S. Frank and Patricia F.E.M. Nievelstein). Renal Transplant Arteriopathy; Similarities to Atherosclerosis (Ekkehard Vollmer and Albert Roessner). Collagens and Collagen Synthesis in the Atherosclerotic Vessel Wall (Jürgen Rauterberg and Elisabeth Jaeger). Regulation of Biosynthetic Activity in Aortic Smooth Muscle Cells by Extracellular Matrix Components (Michael Thie). Vascular Cell Responses to Injury: Modulation by Extracellular Matrix and Soluble Factors (Joseph A. Madri and Leonard Bell). Cytochemical Characterization and Mapping of Glycoconjugates in Arterial Tissues and Vascular Cell Cultures by Light and Electron Microscopy (Wolfgang Völker). Role of Modified Lipoproteins in Atherosclerosis (Wulf Palinksi). Characterization of Lipoprotein Metabolism in Cells Isolated from Atherosclerotic Arteries (Olli Jaakkola). Endocytosis of Lipoproteins and Cholesterol Homeostasis (Horst Robenek and Nicholas J. Severs). c. 250 pp., 6-1/8 x 9-1/4, due September 1992, ISBN 0-8493-5505-2.FEATURES:

Read more less

Book SynopsisA concise, in-depth analysis of the status of the sympathetic system in heart diseasesThis book summarizes the functional status of the sympathetic neural system in cardiological diseased states and highlights aspects of sympathetic neural activity that are important to an overall understanding of the pathophysiology processTable of ContentsCardiac Sympathetic System: Basic Aspects (Pallab K. Ganguly and Guy R. Sherwood). Evaluation of Functional Status of Sympathetic System (Animesh Sahai and Pallab K. Ganguly). Levels of Catechols and the Clinical Assessment of Sympathoadrenal Activity (Davis S. Goldstein). The Contribution of Animal Models to Understanding Neuroadrenergic Responses to Heart Failure (Gordon L. Pierpont). Catecholamines and Congestive Heart Failure: Neuroendocrine Interactions (Gary S. Francis and Kenneth M. McDonald). Functional Status of the Sympathetic Nervous System in Cardiovascular Disease-The Role of Norepinephrine in the Production of Physiologic and Pathologic Hypertrophy (Michael M. Laks). Functional Status of Sympathetic System in Cardiovascular Diseases (Liane Will-Shahab and Bernd Schubert). Functional Status of the Cardiac Sympathetic System in Diabetes (Shawn C. Black and John H. McNeill). Central Control of Cardiac Hypertrophy (Nobby D. Woo, William A. Anderson, and Pallab K. Ganguly). Changes in Central Catecholaminergic Neuron in Cardiovascular Diseases (Bevyn Jarrott). Cardiac Adrenergic Receptors in Cardiovascular Diseases (Constantinos J. Limas and Catherine Limas). Sympathetic Nervous System Activity and Regulation of Cardiac Gene Expression (Heinz Rupp and Nobuakira Takeda). Stress, Catecholamines, and Heart Disease (Robert E. Beamish, Pawan K. Singal, and Pallab K. Ganguly). Catecholamines and Heart Disease: Status of Phospholipid Signaling Pathways (Johanna T.A. Meij and Vincenzo Panagia). Catecholamines and Heart Diseases: Possible Metabolic Interventions (Sujata Majumder, Pawan K. Singal, and Pallab K. Ganguly). Catecholamines and Cardiorenal Disease: Dopamine Receptor Agonists (Barry A. Berkowitz). Index. 304 pp., 7x10, 1991, ISBN 0-8493-5810-8. FEATURES:

Read more less

Book SynopsisSelected as an outstanding book in vascular surgery by members of the Society for Vascular Surgery.*This unique new text describes the current understanding of the etiology and pathogenesis of human atherosclerosis. It also details the methods for quantitating and characterizing both experimental and clinical lesions, and describes the methods for preparing available animal models. Providing an in-depth review of each of these topics, the text organizes the information in one volume for the convenience of the reader. The text is divided into two sections. First is a description of the cell biology, biochemistry and pharmacology of normal vessels and of atherosclerotic human lesions, with details of the methods to accurately characterize and quantitate the disease. Secondly, it presents a description of the methods for preparing the available experimental animal models, including a discussion of the distribution and pathological characteristics of the lesions. It also inTable of ContentsTHE HUMAN ATHEROSCLEROTIC LESION. Theory of Atherosclerosis. Epidemiology and Anatomic Distribution of Atherosclerosis in Man. QUANTITATIVE ASSESSMENT OF ARTERIAL WALL COMPONENTS. Contemporary Concepts in Atherosclerosis Pathology. Pathology of the Extracellular Matrix in Atherosclerosis: In-Vivo and In-Vitro Models. Pharmacology of the Arterial Wall. ANIMAL MODELS OF ATHEROSCLEROSIS. Atherosclerosis in Pigeons. The Use of Rodents for the Study of Atherogenesis and Obesity: The Development of Potential Genetic Models. Rabbit Models of Atherosclerosis. Swine Models of Atherosclerosis. Canine Models of Atherosclerosis. Non-Human Primate Atherosclerotic Models. Atherosclerosis and Healing Abnormalities in Clinical and Experimental Vascular Grafts. Research Needs and Future Perspectives. Index

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisSummarizes concepts concerning the epidemiology, etiology, risk factors, neuropathology and pathogenesis of Vascular dementia (VAD) and Alzheimer's disease (DAT), and mixtures of the two, and reviews their multiple causes, including microvascular and hemorrhagic lesions, and ischemic and inflammatory changes affecting both white and gray matter.Table of ContentsContributors iii Foreword Honorary editor: James F. Toole, President of World Federation of Neurology ivPreface Editors: John S. Meyer, Gaiane M. Rauch, Helmut Lechner, Carlo Loeb, James F. Toole vi Chapter 1 Epidemiology of Vascular Dementia 1Md. Anwarul Haque, John S. Meyer, Gaiane M. Rauch Chapter 2 Cardiovascular Risk Factors Contributors to Cerebral Degenerative Changes, Cognitive Decline, and Dementia 19John S. Meyer, Gaiane M. Rauch, Ronald A. Rauch Chapter 3 Risk Factors for Vascular Dementia 41Helmut Lechner Chapter 4 Neuropathological Correlates of Vascular Dementia 59Carlo Loeb Chapter 5 Microvascular Pathology in Vascular and Related Dementias 77Alberto Portera-Sanchez, Jesus Porta-Etessam Chapter 6 Recent Advances in Vascular Dementia Research 101David W. Desmond Chapter 7 Clinical Feautures of Patients with Vascular Dementia Versus Alzheiner’s Disease 119Gaiane M. Rauch, john S. Meyer Chapter 8 Neuropsychological Assessments for Cognitive Decline 131Md. Anwarul Haque, John S. Meyer, Gaiane M. Rauch Chapter 9 Subcortical Arteriosclerotic Encephalopathy Binswanger Type or Chronic Microvascular Leukoencephalopathy Syndrome 155Carlo Loeb Chapter 10 Criteria for Diagnosis of Vascular Dementia 181Carlo Loeb, John S. Meyer, Gaiane M. Rauch Chapter 11 Classification of Subtypes of Vascular Dementia Including Subcortical Versus Cortical Dementias 203John S. Meyer, Gaiane M. Rauch Chapter 12 Neuroimaging in Vascular Dementia 221John S. Meyer, Gaiane M. Rauch. Ronald A. Rauch Chapter 13 Clinical Observation During Long-Term Follow-Up of Outcome in Vascular Dementia 235Helmut Lechner, Gotz Bertha Chapter 14 Prevention and Treatment of Vascular Dementia 251John S. Meyer, Gaiane M. Rauch Chapter 15 Scientific Basis for Plasmapheresis in Vascular Dementia 263Helmut Lechner Chapter 16 Estrogen Therapy for Prevention of Dementia in Postmenopausal Women 279Gaiane M. Rauch, John S. Meyer Chapter 17 Factors Influencing Long-Term Survival Among Patients with Vascular Dementia Versus Alzheimer’s Disease 289John S. Meyer, Gaiane M. Rauch Index 307

Read more less

Book SynopsisIn the course of understanding the mechanism and therapy of atrial tachycardia, important distinctions are emerging in electrophysical evaluations of various atrial arrhythmias. This is a review of the latest knowledge in the field.Table of ContentsIntroduction. II. Definitions. III. Electrophysiologic Mechanisms. 1. Reentry. 2. Abnormal Automaticity. 3. Triggered Activity. IV. Focal Atrial Tachycardia. 1. Clinical and Electrocardiographic Presentation. The Role of P Wave Configuration. Tachycardia-Induced Cardiomyopathy. Multifocal Atrial Tachycardia. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. The Role of Newer Technologies for Mapping and Ablation of Atrial Tachycardia. The Role of Atrial Anatomy. V. Atrial Fibrillation as a Manifestation of Focal Atrial Activation. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VI. Incisional Intraatrial Reentrant Tachycardia. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VII. Inappropriate Sinus Tachycardia. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VIII. Conclusion. References. Index.

Read more less

Book SynopsisIn this book Dr Edwards shares his vast experience in a discussion of the fundamental anatomy and physiology associated with congenital heart disease. The text provides succinct descriptions of the common and uncommon abnormalities of congenital heart disease and the principles underlying their treatment, while 200 figures clearly demonstrate and guide the user to understand the essential nature of the characteristic defects and abnormalities discussed.Table of ContentsAcknowledgements. Foreword. Guest Preface. Preface. Recollections. Abbreviations. Variations of Bodily Organs. Atrial Anomalies. Ventricular Anomalies. Atrioventricular Cushion Defect. Myocardial Disease. Single Ventricle. Complete Transposition. Corrected Transposition. Double Outlet Right Ventricle. Tetralogy of Fallot. Anomalies of Pulmonary Arteries. Persistent Truncus Arteriosus. Anomalies of Coronary Vessels. Valvular and Related Anomalies. Aortic Atresia. Pulmonary Atresia. Mitral Atresia. Tricuspid Atresia. Aortic Stenosis. Subaortic Stenosis. Pulmonary Stenosis. Mitral Stenosis and Similar Functional Entities. Aortic Regurgitation. Pulmonary Regurgitation. Mitral Regurgitation. Tricuspid Dysplasia and Regurgitation in Ebstein's Malformation. Patent Ductus Arteriosis and AP Window. Aortic Sinus Aneurysm. Aortic Coarctation. Supravalvular Aortic Stenosis. Hypoplasia or Interruption of the Aortic Arch. Vascular Rings and Vascular Slings. Anomalies of Pulmonary Veins. Vena Caval Systems. Asplenia and Polysplenia. References. Index

Read more less

Book SynopsisPractical Management of Pediatric Cardiac Arrhythmias offers a useful source of current, practical information on the diagnosis and management of arrhythmias in children, and is intended for all caregivers, from novice to expert, who treat children, adolescents, and young adults with arrhythmias.Trade Review"The book serves as a useful source of current information and practical data regarding the diagnosis and management of pediatric arrhythmias and appeals to all aspects of caregiving. "Much of the book could serve as a nursing care manual. The approach is succinct and practical, deemphasizing electrophysiology basic science. "This is a valuable, practical addition to a field of medicine which is sometimes obscure. The book is very useful for the practicing nurse or physician." --Doody’s Review Service "I applaud the authors for their well-demonstrated effort to remember that treating the whole person in pediatrics means treating the whole family. Each of these sections not only reminds the clinician of the educational and emotional needs of the family of a child with a newly diagnosed arrhythmia, but also suggests strategies for promoting acceptance, understanding, and compliance. Overall, this book is an important addition to the library of any clinician who is involved in the care of a child with cardiac arrhythmias." --Critical Care NurseTable of ContentsForeword. Thomas P. Graham, Jr., MD. Chapter 1. Mechanisms, Diagnostic Tools, and Patient and Family Education. Vicki L. Zeigler, RN, MSN, Dianne Marlow, RN, BSN, CLNC and Paul C. Gillette, MD. Chapter 2. Supraventricular Arrhythmias. Sarah S. LeRoy RN, MSN, CPNP and Macdonald Dick II, MD. Chapter 3. Ventricular Arrhythmias. Vicki L. Zeigler, RN, MSN and Paul C. Gillette, MD. Chapter 4. Immediate Arrhythmia Management. Barbara J. Knick, RN, CVT and J. Phillip Saul, MD. Chapter 5. Long-Term Antiarrhythmic Drug Therapy. Debra G. Hanisch, RN, MSN, CPNP and George F. Van Hare, MD. Chapter 6. Radiofrequency Catheter Ablation. Dianne Marlow, RN, BSN, CLNC and Paul C. Gillette, MD. Chapter 7. Permanent Pacemakers. Sherry J. Taylor, RN, BSN, Vicki L. Zeigler, RN, MSN, and John M. Clark, MD. Chapter 8. Implantable Cardioverter Defibrillators. Vicki L. Zeigler, RN, MSN, Karen Corbett, PhD, RN, Ann Lewis, RN, BSN, and Paul C. Gillette, MD. Index

Read more less

Book SynopsisIntroduces the knowledge and skills needed to analyze symptoms, physical findings, and ECG and x-ray abnormalities in order to accurately diagnose more than 50 different conditions that may bring about a complaint of 'chest pain'. This book concentrates on causative syndromes or maladies, from its initial presentation to its etiology.Trade Review"This book...is worth owning. It is not going out of date next year!" William C. Roberts American Journal of CardiologyTable of ContentsPreface. Chapter 1. An Explanation of the Title and General Comments. J. Willis Hurst, M.D. PART I: Skin Disease as a Cause for "Chest Pain". Chapter 2. "Chest Pain" in Patients with Herpes Zoster (Shingles). Calvin O. McCall, M.D. and S. Wright Caughman, M.D.. PART II: Musculoskeletal Diseases as a Cause for "Chest Pain". Chapter 3. "Chest Pain" in Patients with Costochondritis or Tietze's Syndrome. Byron R. Williams, M.D.. Chapter 4. "Chest Pain" in Patients with Thoracic Outlet Syndromes. Vinod H. Thourani, M.D. and Joseph I. Miller, Jr., M.D.. Chapter 5. "Chest Pain" in Patients with Chest Wall Syndromes. J. Willis Hurst, M.D. Chapter 6. "Chest Pain" in Patients with the Shoulder-Hand Syndrome. Mark E. Silverman, M.D.. Chapter 7. "Chest Pain" in Patients with Bursitis of the Shoulder. Stephen B. Miller, M.D. Chapter 8. "Chest Pain" in Patients with Rotator Cuff Tendonitis or Arthritis of the Shoulder. Andrew P. Gutow, M.D. Chapter 9. "Chest Pain" in Patients with Joint Disease of the Cervical or Thoracic Spine. Stephen B. Miller, M.D.. PART III: Thrombophlebitis as a Cause for "Chest Pain". Chapter 10. "Chest Pain" in Patients with Mondor's Syndrome. Stephen D. Clements, Jr., M.D.. PART IV: Neurologic Disease as a Cause for "Chest Pain". Chapter 11. "Chest Pain" in Patients with Cervical Disc Syndromes. David J. Hewitt, M.D. Chapter 12. "Chest Pain" in Patients with Brachial Plexus Neuropathy. David J. Hewitt, M.D. PART V: Mediastinal Disease as a Cause for "Chest Pain". Chapter 13. "Chest Pain" in Patients with Mediastinal Emphysema. Talmadge E. King, Jr., M.D. PART VI: Pulmonary Causes of "Chest Pain". Chapter 14. "Chest Pain" in Patients with Pleuritis. Talmadge E. King, Jr., M.D.. Chapter 15. "Chest Pain" in Patients with Pneumothorax. Talmadge E. King, Jr., M.D.. Chapter 16. "Chest Pain" in Patients with Pulmonary Embolism. Nanette K. Wenger, M.D. Chapter 17. "Chest Pain" in Patients with "Café" Coronary. Stephen D. Clements, Jr., M.D. PART VII: Diseases of the Gastrointestinal Tract as a Cause for "Chest Pain". Chapter 18. "Chest Pain" in Patients with Esophageal Motility Disorders. J. Patrick Waring, M.D. Chapter 19. "Chest Pain" in Patients with Gastroesophageal Reflux. J. Patrick Waring, M.D. Chapter 20. "Chest Pain" in Patients with Esophageal Rupture. J. Patrick Waring, M.D. Chapter 21. "Chest Pain" in Patients with Esophageal Stenosis. J. Patrick Waring, M.D. Chapter 22. "Chest Pain" in Patients with Pill-Induced Esophagitis. J. Patrick Waring, M.D. Chapter 23. "Chest Pain" of Esophageal Origin in Patients with HIV. J. Patrick Waring, M.D.. Chapter 24. "Chest Pain" in Patients with Peptic Ulcer Disease. Steve Goldschmid, M.D. PART VIII: Diseases of the Gallbladder and Biliary Tract as Causes of "Chest Pain". Chapter 25. "Chest Pain" in Patients with Biliary Colic. Steve Goldschmid, M.D. Chapter 26. "Chest Pain" in Patients with Acute Cholecystitis. Steve Goldschmid, M.D. PART IX: Pericardial Disease as a Cause for "Chest Pain". Chapter 27. "Chest Pain" in Patients with Acute Pericarditis. David H. Spodick, MD, DSc. PART X: Heart Disease as a Cause for "Chest Pain". Chapter 28. "Chest Pain" in Patients with Cardiac Arrhythmias. Paul F. Walter, M.D. and J. Willis Hurst, M.D.. Chapter 29. "Chest Pain" in Patients with Angina Pectoris. J. Willis Hurst, M.D. Chapter 30. "Chest Pain" in Patients with Myocardial Infarction. Douglas C. Morris, M.D. Chapter 31. "Chest Pain" in Patients with Prinzmetal''s Angina. David Waters, M.D. and Rabih R. Azar, M.D., M.Sc. Chapter 32. "Chest Pain" in Patients with Myocardial Infarction with Normal or Near Normal Coronary Arteriogram. Rabih R. Azar, M.D., M.Sc. and David Waters, M.D.. Chapter 33. "Chest Pain" in Patients Who Use Cocaine. Jessica Haberer, M.D. and David Waters, M.D.. Chapter 34. "Chest Pain" in Patients with Congenital Heart Disease. Joseph K. Perloff, M.D.. Chapter 35. "Chest Pain" in Patients with Aortic Valve Stenosis. Douglas C. Morris, M.D. Chapter 36. "Chest Pain" in Patients with Aortic Valve Regurgitation. Douglas C. Morris, M.D. Chapter 37. "Chest Pain" in Patients with Rheumatic Mitral Valve Stenosis. Douglas C. Morris, M.D. Chapter 38. "Chest Pain" in Patients with Hypertrophic Cardiomyopathy. Douglas C. Morris, M.D.. Chapter 39. "Chest Pain" in Patients with Dilated Cardiomyopathy. Douglas C. Morris, M.D. Chapter 40. "Chest Pain" in Patients with Restrictive Cardiomyopathy. Douglas C. Morris, M.D. Chapter 41. "Chest Pain" in Patients with Pulmonary Hypertension. Robert C. Schlant, M.D. Chapter 42. "Chest Pain" in Patients with Systemic Hypertension. J. Willis Hurst, M.D. PART XI: "Chest Pain" Caused by Diseases of the Aorta. Chapter 43. "Chest Pain" in Patients with Aortic Dissection. Joseph Lindsay, Jr., M.D. Chapter 44. "Chest Pain" in Patients with Aortic Aneurysms. Joseph Lindsay, Jr., M.D. PART XII: "Chest Pain" Related to Emotional or Psychiatric Conditions. Chapter 45. "Chest Pain" in Patients with Anxiety Disorders. Bernard L. Frankel, M.D.. Chapter 46. "Chest Pain" in Patients with Depressive Disorders. Bernard L. Frankel, M.D.. Chapter 47. "Chest Pain" in Patients Who Are Malingering. James C. Hamilton, Ph.D. and Marc D. Feldman, M.D.. Chapter 48. "Chest Pain" in Patients with Factitious Disorder Including Munchausen Syndrome. Marc D. Feldman, M.D. and James C. Hamilton, Ph.D.. Chapter 49. "Chest Pain" in Patients with Addiction. Karen Drexler, M.D.. PART XIII: "Chest Pain" of Controversial Origin. Chapter 50. "Chest Pain" in Patients with Syndrome X. Richard O. Cannon III, M.D.. Chapter 51. "Chest Pain" in Patients with Mitral Valve Prolapse. J. Willis Hurst, M.D.. PART XIV: Final Comments. Chapter 52. The Evolution of our Knowledge and Remaining Problems. J. Willis Hurst, M.D.

Read more less

Book SynopsisEdited by Valentin Fuster, former Chairman of the American Heart Associationa s Committee on Vascular Lesions, Assessing and Modifying the Vulnerable Atherosclerotic Plaque explores the cutting--edge developments in a steadily advancing field.Table of ContentsHistorical Perspective. Contributors. Chapter 1. Evolving Concepts of Atherothrombosis (Valentin Fuster, MD, PhD and Roberto Corti, MD). Chapter 2. Cerebrovascular Diseases: Pathophysiology and Management (Debabrata Mukherjee, MD and Jay S. Yadav, MD). Chapter 3. Aortic Arch Vulnerable Plaques: Update (Pierre Amarenco, MD and Ariel Cohen, MD, PhD). Chapter 4. The Vulnerable Atherosclerotic Plaque in Peripheral Vascular Disease (Michael L. Marin, MD, Larry H. Hollier, MD, Valentin Fuster, MD, PhD, and Jeffrey Goldman, MD). Panel Discussion I. Overview of Pathology: Clinical Correlations of Atherosclerosis. Chapter 5. Thermography: A Novel Approach for Identification of Plaques at Risk of Rupture and/or Thrombosis (Mohammad Madjid, MD, Morteza Naghavi, MD, James T. Willerson, MD, and Ward Casscells, MD). Chapter 6. Intravascular Ultrasound and Plaque Vulnerability: Evidence of a Systemic Disease Process (Paul Schoenhagen, MD and Steven E. Nissen, MD, FACC). Chapter 7. Intracoronary Angioscopy to Detect Vulnerable Plaques: A Technique Whose Time Has Come? (Sergio Waxman, MD). Chapter 8. Electron Beam Computed Tomography in Assessing the Vulnerable Atherosclerotic Plaque (Robert A. O'Rourke, MD). Chapter 9. Multirow-Detector Helical Computed Tomography (Christoph R. Becker, MD, Uwe J. Schoepf, MD, and Maximilian F. Reiser, MD). Panel Discussion IIA. Overview of Imaging: Coronary Atherosclerosis. Chapter 10. Imaging of the High-Risk Plaque Using Magnetic Resonance Imaging (Zahi A. Fayad, PhD and Valentin Fuster, MD, PhD). Chapter 11. Cardiovascular Imaging with Optical Coherence Tomography (Mark E. Brezinski, MD, PhD and James Fujimoto, PhD). Panel Discussion IIB. Overview of Imaging: Atherosclerotic Regions and Imaging Modalities. Chapter 12. Plaque Instability and Remodeling: Mechanisms and Possible Misconceptions (Trine-Line Korsholm, MS, Gerard Pasterkamp, MD, PhD, MSc, and Erling Falk, MD, PhD). Chapter 13. Structural and Cellular Components of the Vulnerable Plaque: Extracellular Matrix (Renu Virmani, MD, Frank D. Kolodgie, PhD, Allen P. Burke, MD, Andrew Farb, MD, and Thomas N. Wight, PhD). Chapter 14. Structural and Cellular Components of the Vulnerable Plaque: Inflammatory Cells (Allard C. van der Wal, MD, PhD, Mischa A. Houtkamp, MSc, Onno J. de Boer, PhD, and Anton E. Becker, MD, PhD). Panel Discussion III. Structural and Cellular Components of the Vulnerable Atherosclerotic Plaque. Chapter 15. Stress and Strain: Biomechanical Guides for Imaging Plaque Stability (Hayden Huang, DSc and Richard T. Lee, MD). Chapter 16. Endothelium, Flow, and Atherothrombosis (Roberto Corti, MD, Lina Badimon, PhD, Valentin Fuster, MD, PhD, and Juan Jose Badimon, PhD). Chapter 17. Activities that Trigger Plaque Disruption (Jagmeet P. Singh, MD, DM, PhD, James Januzzi, MD, and James E. Muller, MD). Panel Discussion IV. Mechanical Forces in Plaque Disruption. Chapter 18. Matrix Metalloproteinases and Their Inhibitors (Uwe Schönbeck, PhD and Peter Libby, MD). Chapter 19. Calcium Deposition in Vulnerable Atherosclerotic Plaques: Pathophysiologic Mechanisms and Potential Implications in the Acute Coronary Syndromes (Pedro R. Moreno, MD). Panel Discussion V. Regulation of Functional Components of the Vulnerable Plaque. Index.

Read more less

Book SynopsisDrs. Bharati and Lev share the knowledge they''ve accumulated through the study of the pathology of congenital heart disease as seen in this century. Their detailed studies of over 6,300 congenitally malformed hearts give them a unique and comprehensive perspective on this topic. This monograph reports the results of their analyses and includes 2,700 excellent photographs. This book will be of significant interest to those working with or studying about congenital heart disease. This book will help clinicians and surgeons to diagnose congenital heart disease. Likewise, it offers protocol for correcting the lesions, nonsurgically and surgically. Concurrently, the text offers fertile ground for selective basic science specialities: genetics, immunology and molecular biology. Epidemiologists, statisticians and computer experts will want to review this book.Trade Review"This is a good, short compilation of data on relatively rare forms of ventricular tachycardia, that is, those found in the structurally normal heart. This book provides a ready reference on these patients as well as an extensive reference list for further review in a specific area as needed." (Cardiology News) "...an excellent book which serves as a superb summary of an exploding field of knowledge. I would highly recommend this text for cardiology house officers, general cardiologists, and internists interested in arrhythmias." (PACE)Table of ContentsAcknowledgments. Preface. Abbreviations Used in This Book.. VOLUME 1. Part I. 1. Introduction. 2. General Concepts in Pathology of Congenital Heart Disease. 3. Methods of Examination. 4. Dissection of the Heart. 5. Internal Examination. 6. Anatomy of the Normal Heart. 7. Architecture of the Ventricular Myocardium. 8. Embryology of the Heart. 9. Terminology and Classification.. Part II. 10. Tetralogy of Fallot. 11. Double Outlet Right Ventricle: General Concepts and Subaortic Ventricular Septal Defect. 12. Double Outlet Right Ventricle with Doubly Committed and Noncommitted Type of Ventricular Septal Defect. 13. Double Outlet Right Ventricle: Complicated Types. 14. Double Outlet Right Ventricle with Subpulmonic Ventricle Septal Defect: Taussig-Bing Right Ventricular Type and Mild Overriding of the Pulmonary Trunk. 15. Taussig-Bing Group of Hearts: Taussig-Bing Intermediate and Left Ventricular Types. 16. A Concept of Transposition: Complete Transposition with Normal Architecture Without Ventricular Septal Defect. 17. Complete Transposition with Normal Architecture with Ventricular Septal Defect. 18. Complete Transposition with Pulmonary Stenosis. 19. Complete Transposition with Common Ventricle. 20. Complete Transposition with Tricuspid Stenosis. 21. Complete Transposition with Tricuspid Atresia. 22. Complete Transposition with Mitral Atresia or Marked Mitral Stenosis. 23. Complete Transposition with Common Atrioventricular Orifice. 24. Unusual Complete Transposition Complexes: Double Outlet Left Ventricle. 25. Truncus Arteriosus Communis. 26. Pulmonary Atresia with Ventricle Septal Defect: Pseudotruncus. 27. Tricuspid Atresia: Tricuspid Atresia Without Transposition. 28. Tricuspid Stenosis Complexes: Tricuspid Stenosis with Pulmonary Atresia. 29. Unusual Tricuspid Stenosis Without Transposition - With Normal or Increased Pulmonary Flow: Tricuspid Stenosis Without Transposition. 30. Atrial Septal Defect, Secundum. 31. Atrial Septal Defect, Primum. 32. Atrial Septal Defect, Proximal Septal: Sinus Venosus Type. 33. Atrial Septal Defect, Coronary Sinus Type. 34. Atrial Septal Defect, Combined Secundum and Primum, or Common Atrium. 35. Ventricular Septal Defect. 36. Common Atrioventricular Orifice: Complete Type. 37. Common Atrioventricular Orifice: Intermediate Type. 38. Total Anomalous Pulmonary Venous Drainage. 39. Partial Anomalous Pulmonary Venous Drainage. 40. Patent Ductus Arteriosus. 41. Aorticopulmonary Septal Defect. 42. Atrial Septal Defect and Ventricular Septal Defect. 43. Atrial Septal Defect and Patent Ductus Arteriosus. 44. Atrial Septal Defect, Ventricular Septal Defect, and Patent Ductus Arteriosus. 45. Ventricular Septal Defect and Patent Ductus Arteriosus. 46. Hypoplasia of the Aortic Tract Complex. 47. Coarctation of the Aorta: Fetal Coarctation. 48. Transitional Coarctation of the Aorta. 49. Paraductal (Juxtaductal or Adult) Coarctation of the Aorta. 50. Isolated or Pure Pulmonary Stenosis (Normal Aortic Root). VOLUME 2. 51. Ventricular Septal Defect with Pulmonary Stenosis. 52. Aortic Stenosis. 53. Idiopathic Hypertrophy with Fibroelastosis. 54. Origin of One or Both Coronary Arteries from the Pulmonary Arterial Tree. 55. Ebstein's Anomaly. 56. Vascular Rings. 57. Abnormal Position of the Heart or its Component Chambers: Mixed Levocardia. 58. Positional Variations of the Heart and Their Significance. 59. Dextroposition. 60. Dextracardia. 61. Isolated Levocardia. 62. Mesocardia. 63. Single Ventricle with Small Outlet Chamber. 64. Straddling and Displaced Atrioventricular Orifices and Valves (Tricuspid and Mitral). 65. Relationship of Single Ventricle and Small Outlet Chamber to Straddling and Displaced Tricuspid Orifice and Valve. 66. The Concept of Single Ventricle Complex as Distinct from that of Tricuspid Atresia Complex. 67. Inverted Transposition with Left Atrioventricular Valve Atresia: Mixed Levocardia with Ventricular Inversion and Inverted Transposition with Left Atrioventricular Valve Atresia. 68. Glycogen Storage Disease. 69. Gargoylism. 70. Connective Tissue Dyscrasia: Marfan's Syndrome. 71. Congenital Polyvalvular Disease. 72. Congenital Mitral Stenosis. 73. Congenital Mitral Insufficiency. 74. Mitral Atresia with Ventricular Septal Defect Complex. 75. Aortic Atresia with Ventricular Septal Defect. 76. Pulmonary Atresia with Tricuspid Insufficiency. 77. Aortic Stenosis and Mitral Stenosis Complex. 78. Cor Triatriatum Sinistrum (Double Left Atrium). 79. Aneurysm or Ruptured Aneurysm of the Aortic Sinus of Valsalva (or Fistula). 80. Aneurysm of the Coronary Artery with Fistulous Communication with Cardiac Chambers. 81. Abnormal Course or Narrowing of the Pulmonary Trunk and its Branches. 82. Origin of a Right Pulmonary Artery from the Ascending Aorta (Hemitruncus). 83. Abnormal Blood Supply to a Lung from the Thoracic or Abdominal Aorta. 84. Double Heart. 85. Primary Pulmonary Hypertension. 86. Premature Closure or Narrowing of the Foramen Ovale. 87. Absence of Transverse Arch (Interrupted Aortic Arch) with Ventricular Septal Defect. 88. Stenosis or Atresia of the Pulmonary Veins. 89. Other Complexes. 90. Incidental Anomalies. 91. Undiagnosed Hearts. 92. Postoperative Congenital Hearts. 93. Conduction System Problems (Including Sudden Death, Uhl's, Floppy Mitral Valve, Coronary Artery Anomalies, and Atypical Hypertrophic Cardiomyopathy). 94. Congenital Cardiac Malformations Related to Cocaine and/or Other Drug Addiction in the Mother; Normal or Aquired Heart Diseases. 95. Hearts not Examined or Animal. 96. Congenital Hearts Seen According to Complex. 98. The Future. 99. References. Index to Volumes 1 and 2.

Read more less

Book SynopsisThe aim of this book is to provide surgeons with a source of reference for the use of alternative conduits and surgical coronary revascularization methods. A discussion of the standard bypass conduits is presented, in addition to a discussion of the alternative venous and arterial bypass conduits.Trade Review"The push to revascularize the heart with as many arterial grafts as possible is apparent. Grooters and Nishida have provided a complete and thorough discussion involving all the techniques to accomplish this as effectively as possible...all that any coronary artery surgeon could want to know about this subject. The editors have provided an excellent addition to the literature and all coronary surgeons, cardiologists, and anyone interested in the field of vascular reconstruction will enjoy this book. The bibliography alone is worth the price." Journal of Cardiac SurgeryTable of ContentsPreface. R.K. Grooters, H. Nishida. . Part I: The Standard Conduits. 1. The Internal Mammary Artery. R.K. Grooters, H. Nishida. 2. The Greater Saphenous Vein. R.K. Grooters, H. Nishida. . Part II: Alternative Venous Bypass Conduits. 3. The Lesser Saphenous Vein. R.K. Grooters, H. Nishida. 4. The Arm Vein. R.K. Grooters, H. Nishida. 5. The Homologous Veins. R.K. Grooters, H. Nishida. . Part III: Alternative Arterial Bypass Conduits. 6. The Right Gastroepiploic Artery Graft. H. Suma. 7. The Inferior Epigastric Artery. C. Everson, N. Mills. 8. The Radial Artery. R.K. Grooters, H. Nishida. 9. The Splenic Artery. R.K. Grooters, H. Nishida. 10. The Subclavian Artery. R.K. Grooters, H. Nishida. 11. The Lateral Costal Artery. R.K. Grooters, H. Nishida. . Part IV: Alternative Bypass Methods Using the Internal Mammary Artery. 12. Bilateral Internal Mammary Artery Usage. R.K. Grooters, H. Nishida. 13. Sequential Internal Mammary Artery Grafting. R.K. Grooters, H. Nishida. 14. The Internal Mammary Artery Free Graft. R.K. Grooters, H. Nishida. 15. The Composite Graft. R.K. Grooters, H. Nishida. 16. Coronary Bypass Using the Inverted Internal Mammary Artery. R.K. Grooters, H. Nishida. . Part V: Alternative Bypass Methods Using the Saphenous Vein. 17. Sequential Vein Grafting. R.K. Grooters, H. Nishida. 18. The Innominate Artery-Coronary Artery Venous Bypass. R.K. Grooters, H. Nishida. 19. The Sublclavian Artery-Coronary Artery Venous Bypass. R.K. Grooters, H. Nishida. 20. The Coronary-Coronary Bypass Graft. R.K. Grooters, H. Nishida. 21. The Selective Retrograde Coronary Venous Bypass. R.K. Grooters, H. Nishida. 22. Sequential Vein Coronary Artery Grafting With A Surgical Atrial Fistula. H. Nishida, M. Endo, H. Koyanagi, R.K. Grooters. . Part VI: Nonconduit Revascularization Techniques. 23. Patching Techniques for Coronary Artery Revascularization. R.K. Grooters, H. Nishida. 24. Extensive Coronary Artery Endarterectomy. P. Pedraza. 25. Operative Transluminal Coronary Artery Angioplasty. M. Endo. 26. Operative Transluminal Laser Coronary Artery Angioplasty. M. Endo. . Part VII: Artificial Grafts in the Coronary Position. 27. The Past, Present, and Future of Small Diameter Grafts. J.D. Gates, K.C. Kent

Read more less

Book SynopsisA presentation of basic genetic concepts and techniques, this monograph also includes a discussion of the various subtypes of stroke that have genetic components. Organized according to stroke type and mechanism, a section on paediatric stroke also is included.Trade ReviewOverall, this useful book provides the specialist and the general reader with an extensive and up-to-date review of genetic factors that may play a part in cerebrovascular diseases. The chapters are packed with information and have been written clearly. The book is an excellent resource for physicians dealing with cases of cerebrovascular diseases in which the family history suggests the role of inheritance. ...On a whole, this book fills an obvious gap in the field and is therefore a welcome addition to the neurologic and general medical literature." --The New England Journal of Medicine "The audience identified in the preface is both practitioners and researchers. I believe that there is something to be gained from this work for both groups. The editor is certainly reputable in the field and respected. "I enjoyed reading and reviewing this book." --Doody’s Review Service "The broad overview provided together with a comprehensive reference list makes this book a valuable addition to the bookshelf of the neurologist caring for young stroke patients or those with unusual stroke syndromes. Although this is a rapidly evolving field, little of what is contained in this book will necessarily go out of date. Rather it will act as a firm base to which future developments will be added." --BrainTable of ContentsContributors. Preface. Part I. Genetic Principles and Techniques. 1. Genetic concepts and Techniques. M.J. Alberts. 2. Genetic epidemiology and linkage. M.C. Speer. 3. Molecular genetics and gene isolation. M.J. Alberts. . Part II. Genetics of Risk Factors for Cerebrovascular Disease. 4. Genetics of hypertension. L.P. Svetkey, E. O'Riordan, P.J. Conlon, O. Emovon. 5. Molecular Genetics of Lipid Metabolism. C. Graffagnino. 6. Genetic of Atherosclerosis. T.J. DeGraba. 7. Genetics of Coagulation Disorders. T.L. Ortel. . Part III. Genetics of Specific Stroke Etiologies and Syndromes. 8. Genetic Epidemiology and Family Studies of Stroke. L.M. Brass, M.J. Alberts. 9. Inherited Cardiac Diseases that Cause Stroke. M.J. Alberts. 10. Vasculopathies. H. Chabriat, E. Tournier-Lasserve, M-G. Bousser. 11. Intracerebral Hemorrhage and Vascular Malformations. M.J. Alberts. 12. Subarachnoid Hemorrhage and Intracranial Aneurysms. M.J. Alberts. 13. Genetic Causes of Pediatric Stroke. P.I. Andrews, R.S. Kandt. 14. Inherited Systemic Disorders that Cause Stroke. M.J. Alberts. . Part IV. Clinical Applications. 15. Evaluation of Stroke Patients for Inherited Causes of Stroke. M.J. Alberts, J.M. Stajich. 16. Genetic Counseling. S.M. Palmer. 17. Gene Therapy. J.N. Lozier. Index

Read more less

Book SynopsisFinally, a comprehensive yet practical video/text guide on the techniques and clinical considerations related to ICD insertion. Dr. Higgins discusses important related areas too, such as patient selection, O.R. preparation, surgical techniques of lead access, generator implantation and post-operative management, including complications. The 30-minute video presents several different approaches to venous access, proper generator positioning, both subcutaneous and submuscular, as well as pectoral and abdominal sites. As a leading researcher in ICD therapy, Dr. Higgins has participated in over 1,000 such procedures. He was recently one of the principal investigators in the Multicenter Automated Defibrillator Implantation Trial (MADIT), a blind test in which ICD therapy was associated with a 56% reduction in two-year mortality versus those treated with conventional medical therapy. More detailed and case management oriented than any proprietary ICD manufacturer ''in-house''Trade Review"Dr. Higgins provides an important service to cardiology and to the patients who will benefit from the implantation of a transvenous defibrillator. [This is] an authoritative multimedia text that will be an invaluable guide for physicians involved in transplanting transvenous ICD systems." From the Preface by Dr. Arthur J. MossTable of ContentsPreface. Arthur J. Moss, MD. 1. An Introduction to ICDs. • History. • Who Should Implant ICDs?. • An Introduction to the Video. 2. Patient Selection; Site Selection. • Indications. • Risk Factors for ICD Surgery. • Risks of ICD Surgery. • ICD Site Selection. • Preparation of the Patient. 3. The Logistics of ICD Insertion. • Setting Up an ICD Operating Room. • Surgical Instruments. • Staffing for ICD Surgery: Physicians and Support Personnel. • Surgical Support and Consultation. • Anesthesia: Agents and Who Should Administer Them. • Supplies. 4. Venous Access and Lead Positioning. • General Considerations. • The Subclavian Venipuncture Technique. • The Cephalic Vein Cutdown Technique. 5. ICD Lead Positioning and Testing. • ICD Lead Advancement. • DFT Testing. • Optimal Lead Placement: The Endotak-DSP Study. 6. The Subcutaneous Pectoral Approach. • Advantages of the Subcutaneous Approach. • Disadvantages of Subcutaneous Pectoral Approach. • General Surgical Issues. • Antibiotic Usage. 7. Submuscular Pectoral Approach. • Anatomy of the Subpectoral Region. • Anterior Approach. • Lateral (Anterior Axillary) Approach. • Multilayer Closure. 8. Abdominal Generator Techniques. • Anatomy of the Abdominal Wall Region. • Subcutaneous Abdominal ICD Insertion. • Submuscular Abdominal ICD Insertion. • General Surgical Principles for Abdominal ICD Placement. • Techniques for ICD Lead Tunneling. 9. Generator Change Procedures. • Pocket Revision. • Lead Evaluation and Repair. • Pocket Closure. 10. Dressing Care and Postprocedure Management. • Dressing Options. • Immediate Postprocedure Care. • Predischarge Orders. • Postoperative Patient Education. • ICD Support Groups. 11. Management of Complications. • Problems Encountered at Implant. • Problems Encountered in the Immediate Postimplant Period. • Chronic Lead and Device Complications

Read more less

Book SynopsisThis volume is particularly valuable as a current standard reference. It covers all the major vascular operations - carotid endarterectomy, aortoiliac reconstructions and infrainguinal bypasses (in-situ and reversed vein, Dacron and PTFE prosthetic), thoracic and abdominal bypasses - matching each to its competing endovascular procedure. In addition, it provides excellent long-term data on such less common procedures as internal carotid bypass, vertebral artery revascularization, adjunctive procedures to enhance the patency of infrainguinal prosthetic bypass, and percutaneous intentional extraluminal revascularization. Finally, this framework is reinforced by in-depth chapters on current non-interventional management, surveillance programs to enhance long-term patency, and the ultimate challenge for all practicing vascular surgeons - the management of infected aortic grafts. Such clear, comprehensive, and current analysis should be of considerable and on-going vaTrade Review"...a valuable resource that will be of great help in decisions regarding management of vascular patients. It is highly recommended for and will be an important addition to the personal libraries of vascular specialists." (Doody's Review Service) "This book is of most value in providing multiple papers on patency for each specific procedure. These are often illuminating because of the enormous range of reported results. The presentation and tables are impeccable, and the English is of a high standard.... I think that this is a useful book for a department of academic vascular surgery to have on its shelves." (Journal of Vascular Surgery) "The editors are to be congratulated on their enterprise in promoting the 'entente cordiale'." (British Journal of Surger)Table of ContentsContributors. Preface (Robert Rutherford). Foreword (Alain Branchereau, Michael Jacobs). 1. Reporting standards for long-term results of vascular and endovascular surgery (David Bergqvist, Sadettin Karacagil). 2. Long-term results of vascular procedures; medical treatment (Lars Norgren). 3. Long-term surveillance of carotid artery surgical procedures (Michel Reggi, Jean-Michel Jausseran, Michel Ferdani, Francois Houel, Olivier Bayle, Hubert Benichou, Philippe Rudondy). 4. Infrainguinal graft surveillance (Peter Bell). 5. Long-term results of endarterectomy of the carotid bifurcation (Fabien Koskas, Elie Fadel, Hamdi Massoud, Jerôme Cron, Amine Bahnini, Carlo Ruotolo, Edouard Kieffer). 6. Bypass surgery of the internal carotid artery (Jean-Marc Fichelle, Doan Quoc Hong, Francois Cormier, Jean Marzelle, Jean-Michel Cormier). 7. Long-term results of reconstructions of the vertebral artery (Eugenio Rosset, Raouf Ayari, Pierre-Edouard Magnan, Jean-Pierre Mathieu, Bertrand Ede, Alain Branchereau). 8. Long-term results of transthoracic reconstruction of the branches of the aortic arch (Ramon Berguer, Ronald Kline, Mark Morasch). 9. Extrathoracic reconstruction of aortic arch branches (Wilhelm Sandmann, Klaus Grabitz, Tomas Pfeiffer, Ralf Ritter). 10. Bypass procedures for aortoiliac occlusive disease (Andre Nevelsteen, Hendrik Lacroix, Rafael Suy). 11. Late results of aortoiliac endarterectomy (Jose-Maria Capdevila, Juan-Antonio Lopez, Jordi Rancaño, Rafael Abos). 12. Endovascular procedures for aortoiliac occlusive disease (Jim Reekers). 13. Outcome of patients treated for aortic graft infection (Peter Kitslaar, Marcel Barwegen). 14. Descending thoracic aortofemoral bypass for lower limb revascularization (Pierre-Edouard Magnan, Bertrand, Ede, Andrea Ascoli Marchetti, Eugenio Rosset, Jean-Pierre Mathieu, Alain Branchereau). 15. Late results of femorofemoral crossover bypass surgery (AURC & Jean-Baptiste Ricco, Marie-Hélène Bouin-Pineau, Catherine Demarque, Jean-Baptiste Fassier). 16. Long-term results of surgical repair of abdominal aortic aneurysms (Jean-Michel Jausseran, Michel Ferdani, Robert Cataudella, Philippe Rudondy, Enzo Forliti, Jean Rezzi, Michel Reggi). 17. Projections for long-term outcome of endoluminal repair of abdominal aortic aneurysms (James May, Geoffrey H. White, Weiyun Yu, Richard Waugh, Michael Stephen, John P. Harris). 18. Long-term results following thoracoabdominal aortic aneurysm repair (Hazim Safi, Charles Miller, Dimitrios Iliopoulos, Gareth Griffiths). 19. Long-term results of descending thoracic aortic aneurysm repair (Edouard Kieffer). 20. Surgical reconstruction of atherosclerotic renal artery disease (Richard Dean). 21. Surgical reconstruction of fibrodysplasia of the renal artery (Hajo Van Bockel, Cornelis Van Rooden, Jary Van Baalen, Leo Schultze Kool, Peter Chang). 22. Long-term results of renal artery aneurysm repair (Xavier Barral, Jean-Pierre Favre, Philippe Reny, Patrick Feugier). 23. Endovascular treatment of renovascular disease (Willem Mali, Erik Beek, Robert Kaatee, Jaap Beutler, Peter Van Den Ven). 24. Revascularization of the celiac and mesenteric arteries (Jean-Georges Kretz, Nabil Chakfe, Salim Edah-Taly, Francois Levy, Marc Beaufigeau). 25. Infrainguinal reversed venous bypass (Torben Schroeder). 26. Long-term results of in-situ vein grafts (Jacques Watelet, Patrick Soury, Didier Plissonnier, Pierre-Yves Litzler, Christophe Peillon, Jacques Testart). 27. Bypass to the arteries of the ankle and foot (Michael Jacobs, Dink Legemate, Ron Balm). 28. Long-term results of PTFE grafts for femoropopliteal and crural disease (Ian Williams, John Wolfe). 29. Dacron bypass for infrainguinal arterial reconstructions (Torbjørn Dahl, Conrad Lange, Hans Myhre). 30. Infrainguinal prosthetic grafts with distal adjunctive procedures (Peter Harris). 31. Percutaneous transluminal angioplasty of the superficial femoral and popliteal artery (Giorgio Agrifoglio, Livio Gabrielli, Adolfo Constantini, Maurizio Domanin, Antonio Rolli, Piergiorgio Sala). 32. Percutaneous intentional extraluminal recanalization (PIER) of femoropopliteal and tibial arteries (Amman Bolia, Nicholas London, Peter Bell). 33. Arterial allografts in limb salvage procedures (Jean-Luc Magne, Philippe Fayard, Issam Farah, Laurent Voirin, Arald Egelhofer, Carmine Seesa, Pierre Delannoy, Henri Guidicelli)

Read more less

Book SynopsisThe long QT syndrome has become the focus of considerable scientific attention because of the discovery of several genes responsible for its development. This book provides an account of this syndrome's history, significance. It shows why the long QT syndrome has been the focus for numerous theories of arrhythmogenesis.Table of ContentsForeword. Preface. Introduction. Historical Note. Electrophysiology Mechanisms for Arrhythmias. Clinical Presentation. Molecular Biology of LQTS. Epidemiology. Diagnosis. Therapy. Conclusion. Index.

Read more less

Book Synopsis

Read more less